Maxcyte (MXCT) Return on Capital Employed (QoQ) (2021 - 2026)
Maxcyte (MXCT) Return on Capital Employed (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.00 |
| Mar 31, 2026 | 247.00 |
| Dec 31, 2025 | -7.00 |
| Sep 30, 2025 | -165.00 |
| Jun 30, 2025 | -200.00 |
| Mar 31, 2025 | -64.00 |
| Dec 31, 2024 | -247.00 |
| Sep 30, 2024 | -87.00 |
| Jun 30, 2024 | -11.00 |
| Mar 31, 2024 | 36.00 |
| Dec 31, 2023 | -74.00 |
| Sep 30, 2023 | -314.00 |
| Jun 30, 2023 | -187.00 |
| Mar 31, 2023 | -351.00 |
| Dec 31, 2022 | -67.00 |
| Sep 30, 2022 | -197.00 |
| Jun 30, 2022 | -158.00 |
| Mar 31, 2022 | 98.00 |
| Dec 31, 2021 | 218.00 |